Avian Psittacosis, Ornithosis, and Chlamydiosis Study Guide
Overview and Clinical Importance
Psittacosis, ornithosis, and chlamydiosis are all names for avian chlamydial infection caused by Chlamydia psittaci. This obligate intracellular bacterium represents a significant zoonotic disease and is a critical topic for the NAVLE examination. The disease affects over 460 bird species from 30 orders and is particularly important in psittacine birds, poultry, and pet birds.
The terminology varies by host species: psittacosis affects parrot-type birds (psittacines), ornithosis affects non-psittacine birds, and avian chlamydiosis is the general term for all chlamydial infections in birds.
Etiology and Pathophysiology
Causative Agent
Chlamydia psittaci is an obligate intracellular, gram-negative bacterium belonging to the family Chlamydiaceae. The organism exhibits a unique biphasic developmental cycle consisting of two distinct forms:
Genotypes and Host Specificity
C. psittaci is classified into multiple genotypes based on the outer membrane protein A (ompA) gene sequence. Major genotypes include A through G, E/B, WC, M56, and others, with specific host preferences:
Transmission and Epidemiology
Transmission Routes
The primary transmission route is horizontal transmission between birds through:
- Inhalation of aerosolized dried feces, respiratory secretions, or feather dust
- Direct contact with infected birds or contaminated surfaces
- Arthropod vectors (mites, lice, flies) - less common
- Vertical transmission through infected eggs
- Parent-to-offspring feeding (regurgitation in some species)
Environmental Persistence
C. psittaci elementary bodies can survive in the environment for several months in dried feces and contaminated materials, especially in cool, dry conditions. The organism is sensitive to:
- Common disinfectants (bleach, quaternary ammonium compounds)
- Heat (greater than 60°C for 10 minutes)
- Desiccation over extended periods
- Direct sunlight and UV radiation
Clinical Signs and Disease Manifestations
General Clinical Presentation
Clinical signs of avian chlamydiosis are highly variable and depend on factors including:
- Host species and age (young birds more susceptible)
- Bacterial strain virulence
- Infectious dose
- Stress levels and concurrent diseases
- Immune status
Species-Specific Presentations
Psittacine Birds: Cockatiels are highly susceptible, often showing conjunctivitis and sinusitis. Chronic carriers common.
Pigeons: Often asymptomatic carriers; respiratory signs when symptomatic.
Poultry: Turkeys more susceptible than chickens; reduced egg production, airsacculitis.
Waterfowl: Frequently infected; often subclinical except during stress or breeding.
Pathological Findings
Gross Pathology
Gross lesions are often non-specific but may include:
- Hepatosplenomegaly with yellow discoloration
- Airsacculitis with cloudy, thickened air sacs
- Pericarditis and peritonitis with fibrinous exudate
- Pneumonia with consolidation
- Enlarged kidneys with urate deposits
Histopathology
Microscopic findings include:
- Intracytoplasmic inclusion bodies in epithelial cells and macrophages
- Granulomatous inflammation in liver, spleen, and lungs
- Necrosis of hepatocytes and macrophages
- Heterophilic and lymphoplasmacytic inflammation
Diagnosis
Definitive diagnosis of avian chlamydiosis requires laboratory confirmation as clinical signs are non-specific. Multiple diagnostic approaches should be used for accurate diagnosis.
Sample Collection
Preferred samples for live birds include:
- Combined conjunctival, choanal, and cloacal swabs (same swab)
- Fresh feces collected over 3-5 days (intermittent shedding)
- Whole blood or serum for serology
Post-mortem samples:
- Liver, spleen, kidney, lung, air sacs
- Impression smears of affected organs
Interpretive Guidelines
PCR: Single positive result is diagnostic. Multiple samples over 3-5 days increase detection rate due to intermittent shedding.
Serology: Four-fold rise in titer between acute and convalescent samples (2-3 weeks apart) or single high titer (greater than 1:64) in symptomatic bird.
Cytology: Giemsa, Giménez, or Macchiavello stains reveal basophilic intracytoplasmic inclusions.
Treatment
Treatment of avian chlamydiosis requires prolonged antimicrobial therapy due to the intracellular nature of the organism and its biphasic lifecycle.
First-Line Treatment
Doxycycline is the antimicrobial of choice for treating avian chlamydiosis:
Alternative Treatments
When doxycycline is contraindicated or unavailable:
- Enrofloxacin: 15-20 mg/kg PO q12h for 21-45 days
- Azithromycin: 40-80 mg/kg PO q24h for 21 days (3 days on, 3 days off cycle)
- Clarithromycin: 50 mg/kg PO q12h for 21 days
Treatment Considerations
- Treat ALL birds in contact with infected bird, even if asymptomatic
- Supportive care: fluid therapy, nutritional support, warmth
- Reduce calcium sources during oral doxycycline treatment
- Monitor for treatment response and adverse effects
- Post-treatment testing recommended 2-4 weeks after completion
Prognosis
The prognosis for avian chlamydiosis depends on several factors:
Early diagnosis and treatment: Good to excellent prognosis when treated promptly and appropriately.
Species variation: Mortality can range from less than 10% to over 50% depending on species susceptibility.
Treatment completion: Birds may become chronic carriers if treatment is incomplete, leading to recurrence during stress.
Concurrent disease: Prognosis worsens with simultaneous infections or immunosuppression.
Prevention and Control
Biosecurity Measures
- Quarantine new birds for 45 days with PCR testing
- Regular health monitoring and veterinary examinations
- Avoid overcrowding and minimize stress factors
- Proper nutrition and environmental management
- Isolation and treatment of infected birds
Disinfection Protocols
- Daily cage cleaning with disinfectants (bleach, quaternary ammonium)
- Wet cleaning to prevent aerosolization of contaminated dust
- Separate equipment and materials between bird groups
- Personnel hygiene and protective equipment
Vaccination
Currently, no effective commercial vaccines are available for avian chlamydiosis. Research is ongoing into subunit vaccines targeting the Major Outer Membrane Protein (MOMP), but protection remains incomplete.
Zoonotic Implications
Psittacosis is a significant zoonotic disease that can cause severe pneumonia and systemic illness in humans. Understanding zoonotic risks is crucial for veterinary professionals.
Human Disease
Incubation period: 5-14 days (may extend longer)
Clinical signs: Flu-like symptoms progressing to atypical pneumonia, high fever, headache, dry cough
Complications: Endocarditis, myocarditis, encephalitis, hepatitis (rare)
Mortality: Less than 1% with appropriate treatment; historically 20-80% without treatment
High-Risk Occupations
- Veterinarians and veterinary technicians
- Pet shop employees
- Poultry workers and processors
- Zoo personnel and wildlife rehabilitators
- Laboratory workers
Prevention of Human Infection
- Personal protective equipment (masks, gloves, protective clothing)
- Wet cleaning to prevent dust aerosolization
- Proper hand hygiene after handling birds
- Avoid mouth-to-beak contact
- Prompt reporting to public health authorities
Regulatory and Public Health Aspects
Reporting requirements: Psittacosis is reportable in most states and countries. Veterinarians must report suspected cases to public health authorities.
International trade: Import/export regulations require health certificates and quarantine periods for psittacine birds.
Pet industry: Recommended pre-purchase testing and quarantine protocols.
Differential Diagnosis
Clinical signs of chlamydiosis overlap with many conditions. Key differentials include:
Practice NAVLE Questions
Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.
Start Your Free Trial →